Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
[1] The more advanced regulatory activity belongs to the combination product CagriSema (cagrilintide plus semaglutide), which reached Phase 3 and for which a New Drug Application was reported to have been filed with the FDA in late 2025
Pricing: $300 for one month, $550 for two months | Usage: Subcutaneous injection
Once the fridge is out of the kitchen and onto the driveway, it goes into the bag
Dont expect dramatic changes
If you are already established on a GLP-1 medication, please select the tier that aligns with your current weekly dose
US$ 27.03
US$ 21.51
US$ 25.97
